Aspen Pharmacare

Aspen Pharmacare Holdings Limited is a South African multinational pharmaceutical holding company.

Saad owns a 12.5-percent stake in Aspen worth $566 million.

Earlier this year, ImmunityBio opened a plant in South Africa under the name Nant SA.

Saad owns a 12.5-percent stake in Aspen Pharmacare Holdings, worth $566 million.

Saad controls a 12.5-percent stake in the leading drug company.

The vaccine will be marketed as Aspenovax.

The collaboration will enable Africa’s largest drugmaker to increase its production capacity to meet the rising vaccine demand in Africa.

Aspen is a global multinational pharmaceutical company.